HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Weider divests Haleko

This article was originally published in The Tan Sheet

Executive Summary

Weider Nutrition will sell its European subsidiary Haleko to Croatian holding company Atlantic Grupa, the firm announces June 17. Weider will receive roughly $15 mil. in exchange for the capital stock and partnership interests of Haleko's international subsidiaries, the firm adds. Haleko produces and markets brands such as Multipower and Multaben sports nutrition products. The sale allows Weider to focus on its core supplement business, specifically the Schiff Move Free line, with new product initiatives and acquisitions to complement its existing brands, the firm states. Sub-par performance by certain Haleko brands contributed to a 2% reduction in Weider's third-quarter sales and a 53% decline in earnings, the firm noted in April (1"The Tan Sheet" April 11, 2005, p. 18)...
Advertisement

Related Content

Weider’s Schiff Brand Hit By Escalating Raw Material Costs
Weider’s Schiff Brand Hit By Escalating Raw Material Costs

Topics

Advertisement
UsernamePublicRestriction

Register

RS127305

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel